ReviewFrontiers in medicine2022

Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation.

Giorgio Zauli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.